得潤電子(002055.SZ):控股股東解除質押及質押均為1860萬股
格隆匯3月9日丨得潤電子(002055.SZ)公佈,公司接到公司控股股東深圳市得勝資產管理有限公司(“得勝公司”)函告,獲悉其所持有公司的部分股份解除質押及再質押事項,此次解除質押1860萬股,質押1860萬股。
得勝公司及其一致行動人未來半年內到期的質押股份累計數量為3949萬股,佔其所持股份的25.60%,佔公司總股本的8.23%,對應融資餘額為20798.36萬元;未來一年內到期的質押股份累計數量為9342.9萬股,佔其所持股份的60.58%,佔公司總股本的19.48%,對應的融資餘額為60898.36萬元。後續將通過資產處置變現等方式籌措資金進行償還,具備償付能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.